Halil Ateş
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Cell death mechanisms and regulation 2
- Retinoids in leukemia and cellular processes 2
- RNA Interference and Gene Delivery 2
-
- Chronic Myeloid Leukemia Treatments 4
- Platelet Disorders and Treatments 2
- Co-authors
- Sefa Kızıldağ (2 shared papers)Servet Kızıldağ (1 shared paper)Mehmet Ali Özcan (6 shared papers)Hilal Koçdor (2 shared papers)Mehmet Ali Koçdor (2 shared papers)Fatih Demırkan (6 shared papers)Özden Pişkin (7 shared papers)Hale Ören (6 shared papers)
- Journals
- Blood Coagulation & Fibrinolysis (2 papers)Oncology Reports (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Biological Trace Element Research (1 paper)International Journal of Colorectal Disease (1 paper)
- Partner nations
- TürkiyeUnited States
In The Last Decade
Halil Ateş
29 papers receiving 375 citations
Peers
Comparison fields: 5 of 74
- Hematology 79
- Genetics 33
- Pathology and Forensic Medicine 53
- Nutrition and Dietetics 48
- Oncology 69
Countries citing papers authored by Halil Ateş
This map shows the geographic impact of Halil Ateş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Ateş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Ateş more than expected).
Fields of papers citing papers by Halil Ateş
This network shows the impact of papers produced by Halil Ateş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Ateş. The network helps show where Halil Ateş may publish in the future.
Co-authors
The 25 scholars most cited alongside Halil Ateş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 64 | |
| 2 | 2015 | 41 | |
| 3 | 2007 | 29 | |
| 4 | 2006 | 26 | |
| 5 | 2019 | 23 | |
| 6 | 2003 | 22 | |
| 7 | 2020 | 22 | |
| 8 | 2012 | 20 | |
| 9 | 2003 | 18 | |
| 10 | 2019 | 12 | |
| 11 | Corneal recovery in a rabbit limbal stem cell deficiency model by autologous grafts of tertiary outgrowths from cultivated limbal biopsy explants. | 2016 | 11 |
| 12 | 2010 | 11 | |
| 13 | 2003 | 10 | |
| 14 | 2007 | 10 | |
| 15 | Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines. | 2007 | 10 |
| 16 | 2013 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2003 | 7 | |
| 19 | 2005 | 6 | |
| 20 | 2008 | 4 |
About Halil Ateş
Halil Ateş is a scholar working on Molecular Biology, Hematology, Immunology, Genetics and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 384 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), Plant Micronutrient Interactions and Effects (2 papers), Cell death mechanisms and regulation (2 papers), Retinoids in leukemia and cellular processes (2 papers), RNA Interference and Gene Delivery (2 papers), Neonatal Health and Biochemistry (2 papers), Platelet Disorders and Treatments (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Hematology (79 citations), Genetics (33 citations), Pathology and Forensic Medicine (53 citations), Nutrition and Dietetics (48 citations) and Oncology (69 citations). Halil Ateş has collaborated with scholars based in Türkiye and United States. Frequent co-authors include Sefa Kızıldağ, Servet Kızıldağ, Mehmet Ali Özcan, Hilal Koçdor, Mehmet Ali Koçdor, Fatih Demırkan, Özden Pişkin, Hale Ören, Şermin Genç and Neşe Atabey. Their work appears in journals such as Blood Coagulation & Fibrinolysis, Oncology Reports, Anti-Cancer Agents in Medicinal Chemistry, Biological Trace Element Research and International Journal of Colorectal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.